{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T15:40:09Z","timestamp":1776267609791,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1053\/j.ajkd.2007.05.019","type":"journal-article","created":{"date-parts":[[2007,8,29]],"date-time":"2007-08-29T11:02:10Z","timestamp":1188385330000},"page":"421-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Should Hemodialysis Patients With Atrial Fibrillation Undergo Systemic Anticoagulation? A Cost-Utility Analysis"],"prefix":"10.1053","volume":"50","author":[{"given":"Robert R.","family":"Quinn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.J.","family":"Naimark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"Bayoumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 3","key":"10.1053\/j.ajkd.2007.05.019_bib1","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1378\/chest.126.3_suppl.429S","article-title":"Antithrombotic therapy in atrial fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Singer","year":"2004","journal-title":"Chest"},{"key":"10.1053\/j.ajkd.2007.05.019_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/europace\/eul097","volume":"8","author":"Fuster","year":"2006","journal-title":"Europace"},{"key":"10.1053\/j.ajkd.2007.05.019_bib3","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1067\/mhj.2000.111111","article-title":"Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis","volume":"140","author":"Vazquez","year":"2000","journal-title":"Am Heart J"},{"key":"10.1053\/j.ajkd.2007.05.019_bib4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0002-9149(03)00904-4","article-title":"Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis","volume":"92","author":"Vazquez","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.ajkd.2007.05.019_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000180784","article-title":"The risk of anticoagulation in hemodialysis patients","volume":"18","author":"Biggers","year":"1977","journal-title":"Nephron"},{"key":"10.1053\/j.ajkd.2007.05.019_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-5273(02)00317-0","article-title":"Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants?","volume":"87","author":"Vazquez","year":"2003","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.ajkd.2007.05.019_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-4-1","article-title":"Atrial fibrillation in chronic dialysis patients in the United States: Risk factors for hospitalization and mortality","volume":"4","author":"Abbott","year":"2003","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.ajkd.2007.05.019_bib8","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2007.05.019_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2007.05.019_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.1996.307","article-title":"A study of the quality of life and cost-utility of renal transplantation","volume":"50","author":"Laupacis","year":"1996","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.05.019_bib11","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/archinte.1996.00440150083009","article-title":"The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life","volume":"156","author":"Gage","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2007.05.019_bib12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/01.STR.32.6.1425","article-title":"The utility of health states after stroke: A systematic review of the literature","volume":"32","author":"Post","year":"2001","journal-title":"Stroke"},{"key":"10.1053\/j.ajkd.2007.05.019_bib13","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1681\/ASN.V95884","article-title":"The cost of caring for end-stage kidney disease patients: An analysis based on hospital financial transaction records","volume":"9","author":"Bruns","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.05.019_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1345\/aph.1E169","article-title":"Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: A multi-site managed-care study","volume":"39","author":"Menzin","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.ajkd.2007.05.019_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-142-4-200502150-00007","article-title":"A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: Clopidogrel plus aspirin versus aspirin alone","volume":"142","author":"Schleinitz","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2007.05.019_bib16","unstructured":"Agency for Health Care Policy and Research: Healthcare Cost and Utilization Project (HCUP). 1995 HCUP-3 nationwide inpatient sample (NIS), 2005. Available at: www.ahcpr.gov\/data\/hcup\/his95\/clinclas.htm#healthca. Accessed July 25, 2005"},{"key":"10.1053\/j.ajkd.2007.05.019_bib17","unstructured":"Department of Health and Human Services: Changes to the hospital inpatient prospective payment systems and fiscal year 2005 rates. Available at: www.cms.hhs.gov\/providers\/hipps\/frnotices.asp. Accessed July 25, 2005"},{"key":"10.1053\/j.ajkd.2007.05.019_bib18","unstructured":"Centers for Medicare & Medicaid Services: CMS files for download for Medicare payment systems. 2005 physician fee schedule payment amount file national\/carrier. Available at: www.cms.hhs.gov\/providers\/pufdownload\/default.asp#utilmisc. Accessed July 25, 2005"},{"key":"10.1053\/j.ajkd.2007.05.019_bib19","unstructured":"US Department of Labor. Bureau of Labor Statistics: Consumer price indexes. Available at: www.bls.gov\/cpi\/#data. Accessed July 25, 2005"},{"key":"10.1053\/j.ajkd.2007.05.019_bib20","series-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"10.1053\/j.ajkd.2007.05.019_bib21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1525-1497.1998.00211.x","article-title":"Interpretation of cost-effectiveness analyses","volume":"13","author":"Owens","year":"1998","journal-title":"J Gen Intern Med"},{"key":"10.1053\/j.ajkd.2007.05.019_bib22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/027298902400448867","article-title":"Probabilistic analysis of cost-effectiveness models: Choosing between treatment strategies for gastroesophageal reflux disease","volume":"22","author":"Briggs","year":"2002","journal-title":"Med Decis Making"},{"key":"10.1053\/j.ajkd.2007.05.019_bib23","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hec.790","article-title":"Illustrating the impact of including future costs in economic evaluations: An application to end-stage renal disease care","volume":"12","author":"Manns","year":"2003","journal-title":"Health Econ"},{"key":"10.1053\/j.ajkd.2007.05.019_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM199808063390606","article-title":"Gains in life expectancy from medical interventions\u2014Standardizing data on outcomes","volume":"339","author":"Wright","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2007.05.019_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000046216","article-title":"Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation","volume":"21","author":"Wiesholzer","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2007.05.019_bib26","first-page":"107","article-title":"Long-term warfarin treatment may induce arterial calcification in humans: Case report","volume":"27","author":"Schori","year":"2004","journal-title":"Clin Invest Med"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2007.05.019_bib27","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0272-6386(04)01100-X","article-title":"Mortality among hemodialysis patients in Europe, Japan, and the United States: Case-mix effects","volume":"44","author":"Goodkin","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2007.05.019_bib28","first-page":"93","article-title":"The economic cost of dialysis: A comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit","volume":"12","author":"Rodriguez-Carmona","year":"1996","journal-title":"Adv Perit Dial"},{"key":"10.1053\/j.ajkd.2007.05.019_bib29","first-page":"171","article-title":"A cost effectiveness analysis of the treatment of end stage renal failure","volume":"103","author":"Croxson","year":"1990","journal-title":"N Z Med J"},{"key":"10.1053\/j.ajkd.2007.05.019_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-8510(98)00017-7","article-title":"Economic evaluation of end stage renal disease treatment","volume":"44","author":"de Wit","year":"1998","journal-title":"Health Policy"},{"key":"10.1053\/j.ajkd.2007.05.019_bib31","first-page":"455","article-title":"Cost analysis of dialysis treatments for end-stage renal disease (ESRD)","volume":"18","author":"Goeree","year":"1995","journal-title":"Clin Invest Med"},{"key":"10.1053\/j.ajkd.2007.05.019_bib32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/ajkd.2002.34924","article-title":"Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access","volume":"40","author":"Lee","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2007.05.019_bib33","series-title":"US Renal Data System: 2006 Annual Data Report","year":"2006"},{"key":"10.1053\/j.ajkd.2007.05.019_bib34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5414\/CNP60341","article-title":"Quality of life in patients treated with hemodialysis or peritoneal dialysis: What are the important determinants?","volume":"60","author":"Manns","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2007.05.019_bib35","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jama.1995.03530230025025","article-title":"Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation","volume":"274","author":"Gage","year":"1995","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2007.05.019_bib36","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/ndt\/15.11.1808","article-title":"Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis","volume":"15","author":"Iseki","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2007.05.019_bib37","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2007.05.019_bib38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinte.164.8.880","article-title":"The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage","volume":"164","author":"Rosand","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2007.05.019_bib39","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/WNL.56.6.773","article-title":"Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage","volume":"56","author":"Bailey","year":"2001","journal-title":"Neurology"},{"key":"10.1053\/j.ajkd.2007.05.019_bib40","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-120-11-199406010-00001","article-title":"Risk factors for intracranial hemorrhage in outpatients taking warfarin","volume":"120","author":"Hylek","year":"1994","journal-title":"Ann Intern Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860700844X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263860700844X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:48:25Z","timestamp":1759456105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263860700844X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S027263860700844X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2007.05.019","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should Hemodialysis Patients With Atrial Fibrillation Undergo Systemic Anticoagulation? A Cost-Utility Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2007.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2007.07.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}